Baldini N - Search Results

1

SARG: a new human osteosarcoma cell line. Expression of bone markers and of major histocompatibility antigens.

Scotlandi K, Serra M, Landuzzi L, Baldini N. Scotlandi K, et al. Among authors: baldini n. Ann Oncol. 1992 Apr;3 Suppl 2:S29-31. doi: 10.1093/annonc/3.suppl_2.s29. Ann Oncol. 1992. PMID: 1622859 Free article.

2

Adriamycin binding assay: a valuable chemosensitivity test in human osteosarcoma.

Baldini N, Scotlandi K, Serra M, Kusuzaki K, Shikita T, Manara MC, Maurici D, Campanacci M. Baldini N, et al. J Cancer Res Clin Oncol. 1992;119(2):121-6. doi: 10.1007/BF01209668. J Cancer Res Clin Oncol. 1992. PMID: 1358894

3

Evaluation of osteonectin as a diagnostic marker of osteogenic bone tumors.

Serra M, Morini MC, Scotlandi K, Fisher LW, Zini N, Colombo MP, Campanacci M, Maraldi NM, Olivari S, Baldini N. Serra M, et al. Among authors: baldini n. Hum Pathol. 1992 Dec;23(12):1326-31. doi: 10.1016/0046-8177(92)90050-d. Hum Pathol. 1992. PMID: 1468768

4

Induction of HLA class II antigens in osteosarcoma cells by interferons and tumor necrosis factor alpha.

Scotlandi K, Baldini N, Campanacci M, Lollini PL, Picci P, Serra M. Scotlandi K, et al. Among authors: baldini n. Anticancer Res. 1992 May-Jun;12(3):767-72. Anticancer Res. 1992. PMID: 1622136

5

Expression of P-glycoprotein in high-grade osteosarcomas in relation to clinical outcome.

Baldini N, Scotlandi K, Barbanti-Bròdano G, Manara MC, Maurici D, Bacci G, Bertoni F, Picci P, Sottili S, Campanacci M, et al. Baldini N, et al. N Engl J Med. 1995 Nov 23;333(21):1380-5. doi: 10.1056/NEJM199511233332103. N Engl J Med. 1995. PMID: 7477118 Free article.

6

Clinical relevance of Ki-67 expression in bone tumors.

Scotlandi K, Serra M, Manara MC, Maurici D, Benini S, Nini G, Campanacci M, Baldini N. Scotlandi K, et al. Among authors: baldini n. Cancer. 1995 Feb 1;75(3):806-14. doi: 10.1002/1097-0142(19950201)75:3<806::aid-cncr2820750310>3.0.co;2-s. Cancer. 1995. PMID: 7828130

7

The Met/HGF receptor is over-expressed in human osteosarcomas and is activated by either a paracrine or an autocrine circuit.

Ferracini R, Di Renzo MF, Scotlandi K, Baldini N, Olivero M, Lollini P, Cremona O, Campanacci M, Comoglio PM. Ferracini R, et al. Among authors: baldini n. Oncogene. 1995 Feb 16;10(4):739-49. Oncogene. 1995. PMID: 7862451

8

Pre-treatment of human osteosarcoma cells with N-methylformamide enhances P-glycoprotein expression and resistance to doxorubicin.

Scotlandi K, Serra M, Manara MC, Lollini PL, Maurici D, Del Bufalo D, Baldini N. Scotlandi K, et al. Among authors: baldini n. Int J Cancer. 1994 Jul 1;58(1):95-101. doi: 10.1002/ijc.2910580116. Int J Cancer. 1994. PMID: 7912235

9

Establishment and characterization of multidrug-resistant human osteosarcoma cell lines.

Serra M, Scotlandi K, Manara MC, Maurici D, Lollini PL, De Giovanni C, Toffoli G, Baldini N. Serra M, et al. Among authors: baldini n. Anticancer Res. 1993 Mar-Apr;13(2):323-9. Anticancer Res. 1993. PMID: 8100126

10

Polyomavirus latency and human tumors.

De Mattei M, Martini F, Tognon M, Serra M, Baldini N, Barbanti-Brodano G. De Mattei M, et al. Among authors: baldini n. J Infect Dis. 1994 May;169(5):1175-6. doi: 10.1093/infdis/169.5.1175. J Infect Dis. 1994. PMID: 8169418 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

377 results

Search Page

Filters